Gabriele Ricci is the Chief Data and Technology Officer (CDTO) of Takeda Pharmaceutical Company Ltd. He was appointed to this role in February 2022 and leads the transformation of Takeda’s Data, Digital and Technology division.
Mr. Ricci joined Takeda in 2019 as Head of Plasma-Derived Therapies (PDT) IT, during which he drove initiatives to meet the large and growing demand for plasma-derived products, with highly specialized services that require strategic capacity, innovative business models, dedicated R&D and agile supply allocation on a global scale. Prior to joining Takeda, Mr. Ricci served as Head of Digital Health and Emerging Technology at Shire, where he leveraged new and emerging technologies to optimize internal operations and deliver differentiated patient and customer experiences.
Mr. Ricci has also served as Shire’s Head of Technical Operations IT and held leadership positions at Novartis, Johnson & Johnson and Bristol-Myers Squibb. Mr. Ricci brings more than 18 years of information technology and engineering expertise in the life sciences industry and sits on several advisory boards for non-profit organizations focused on digital, life sciences and manufacturing.
Mr. Ricci holds an MBA from the MIB Trieste School of Management and a bachelor’s degree in Engineering from the University of Rome Tor Vergata.